Jubilant Ingrevia (JUBLINGR IN) – Q2FY27 Result Update – Improved Acetyl realizations aided margins YoY – HOLD
Published on 27 Oct 2026
Management reiterated its FY27 EBITDA guidance of INR7.5–8.0bn. Higher acetic acid prices are expected to provide a near-term tailwind for the Chemical Intermediates segment, although a reversal could weigh on margins. Visibility on incremental order inflows under the large agrochemical CDMO contract remains limited. At the current market price, the stock trades at 23x FY28E EPS. Based on our SoTP valuation, we derive a target price of INR649, implying a Sep’28E P/E of 23x, and maintain our HOLD rating.
